Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP688345.RA0Rm4yYuwcZ5Mm66IjyYe_9ExUX-HCjwAPZQUi4fITk4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP688345.RA0Rm4yYuwcZ5Mm66IjyYe_9ExUX-HCjwAPZQUi4fITk4130_assertion type Assertion NP688345.RA0Rm4yYuwcZ5Mm66IjyYe_9ExUX-HCjwAPZQUi4fITk4130_head.
- NP688345.RA0Rm4yYuwcZ5Mm66IjyYe_9ExUX-HCjwAPZQUi4fITk4130_assertion description "[Further understanding of the CXCR4/CXCL12 pathway in SCLC and NSCLC may provide a rationale for innovative research on the CXCR4 receptor as a potential novel therapeutic target in lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP688345.RA0Rm4yYuwcZ5Mm66IjyYe_9ExUX-HCjwAPZQUi4fITk4130_provenance.
- NP688345.RA0Rm4yYuwcZ5Mm66IjyYe_9ExUX-HCjwAPZQUi4fITk4130_assertion evidence source_evidence_literature NP688345.RA0Rm4yYuwcZ5Mm66IjyYe_9ExUX-HCjwAPZQUi4fITk4130_provenance.
- NP688345.RA0Rm4yYuwcZ5Mm66IjyYe_9ExUX-HCjwAPZQUi4fITk4130_assertion SIO_000772 20147779 NP688345.RA0Rm4yYuwcZ5Mm66IjyYe_9ExUX-HCjwAPZQUi4fITk4130_provenance.
- NP688345.RA0Rm4yYuwcZ5Mm66IjyYe_9ExUX-HCjwAPZQUi4fITk4130_assertion wasDerivedFrom befree-20150227 NP688345.RA0Rm4yYuwcZ5Mm66IjyYe_9ExUX-HCjwAPZQUi4fITk4130_provenance.
- NP688345.RA0Rm4yYuwcZ5Mm66IjyYe_9ExUX-HCjwAPZQUi4fITk4130_assertion wasGeneratedBy ECO_0000203 NP688345.RA0Rm4yYuwcZ5Mm66IjyYe_9ExUX-HCjwAPZQUi4fITk4130_provenance.